Literature DB >> 25088522

Tyramine-based enzymatic conjugate repeats for ultrasensitive immunoassay accompanying tyramine signal amplification with enzymatic biocatalytic precipitation.

Li Hou1, Yun Tang, Mingdi Xu, Zhuangqiang Gao, Dianping Tang.   

Abstract

A new impedimetric immunoassay protocol based on enzyme-triggered formation of tyramine-enzyme repeats on gold nanoparticle (AuNP) was designed for highly sensitive detection of carcinoembryonic antigen (CEA, as a model) by virtue of utilizing enzymatic biocatalytic precipitation toward 4-chloro-1-naphthol (4-CN) on anti-CEA antibody (Ab1)-modified immunosensor. Initially, AuNP was functionalized with horseradish peroxidase and detection antibody (HRP-AuNP-Ab2), and then HRP-tyramine conjugate was utilized for the formation of tyramine-HRP repeats through the triggering of the immobilized HRP on the AuNP with the aid of H2O2. In the presence of target CEA, the carried HRP-tyramine repeats accompanying the sandwiched immunocomplex catalyzed the 4-CN oxidation to produce an insoluble precipitation on the immunosensor, thus causing a local alteration of the conductivity. Three signal-transduction tags including HRP-Ab2, HRP-AuNP-Ab2, and HRP-AuNP-Ab2 with HRP-tyramine repeats were employed for target CEA evaluation, and improved analytical properties were achieved by HRP-AuNP-Ab2 with HRP-tyramine repeats. Using the unique signal-transduction tag, the analytical performance of the impedimetric immunoassay was studied in detail. Under the optimal conditions, the impedimetric immunosensor displayed a wide dynamic working range of between 0.5 pg mL(-1) and 40 ng mL(-1) with a detection limit (LOD) of 0.38 pg mL(-1) relative to target CEA. The coefficients of variation (CVs) were ≤9.3% and 13.3% for the intra-assay and interassay, respectively. The levels of CEA in eight clinical serum specimens were measured by using the developed impedimetric immunosensor. The obtained results correlated well with those from the electrochemiluminescent (ECL)-based immunoassay with a correlation coefficient of 0.998.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25088522     DOI: 10.1021/ac501898t

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  6 in total

1.  Development of Improved Double-Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in Peripheral Blood Mononuclear Cells of Diabetic Patients and the Prefrontal Cortex of Multiple Sclerosis Patients.

Authors:  Dongyang Li; Christophe Morisseau; Cindy B McReynolds; Thomas Duflot; Jérémy Bellien; Rashed M Nagra; Ameer Y Taha; Bruce D Hammock
Journal:  Anal Chem       Date:  2020-04-27       Impact factor: 6.986

2.  Nanobody Based Immunoassay for Human Soluble Epoxide Hydrolase Detection Using Polymeric Horseradish Peroxidase (PolyHRP) for Signal Enhancement: The Rediscovery of PolyHRP?

Authors:  Dongyang Li; Yongliang Cui; Christophe Morisseau; Shirley J Gee; Candace S Bever; Xiangjiang Liu; Jian Wu; Bruce D Hammock; Yibin Ying
Journal:  Anal Chem       Date:  2017-05-10       Impact factor: 6.986

3.  Aptamer-based microchip electrophoresis assays for amplification detection of carcinoembryonic antigen.

Authors:  Li Pan; Jingjin Zhao; Yong Huang; Shulin Zhao; Yi-Ming Liu
Journal:  Clin Chim Acta       Date:  2015-09-03       Impact factor: 3.786

Review 4.  Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips.

Authors:  So-Woon Kim; Jin Roh; Chan-Sik Park
Journal:  J Pathol Transl Med       Date:  2016-10-13

5.  Immunocontrolling Graphene Oxide Catalytic Nanogold Reaction and Its Application to SERS Quantitative Analysis.

Authors:  Aihui Liang; Chongning Li; Xiaoliang Wang; Yanghe Luo; Guiqing Wen; Zhiliang Jiang
Journal:  ACS Omega       Date:  2017-10-27

6.  All on size-coded single bead set: a modular enrich-amplify-amplify strategy for attomolar level multi-immunoassay.

Authors:  Desheng Chen; Xiaobo Zhang; Liping Zhu; Chenghui Liu; Zhengping Li
Journal:  Chem Sci       Date:  2022-02-17       Impact factor: 9.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.